Ding et al. reported that pancreatic cancer (PC)-derived EVs carry miR-212–3p, which are responsible for the inhibition of regulatory factor X-associated proteins (RFXAP), an important transcription factor for MHC-II that can lead to immune tolerance in the TME [32]. This evidence concerns the gene RFXAP and pancreatic neoplasm.